Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Hypertension

Rest before blood pressure measurement: a lesson from SPRINT

The SPRINT data suggest a cardiovascular benefit of intensive blood pressure (BP) lowering in high-risk individuals. The BP measurement protocol, however, likely resulted in lower BP values than would normally be obtained in the clinic. Intensive BP targets might not be as safe if routine BP measurements are used.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Wright, J. T. Jr et al. A randomized trial of intensive versus standard blood-pressure control. N. Engl. J. Med. 373, 2103–2116 (2015).

    Article  CAS  Google Scholar 

  2. Agarwal, R., Pappas, M. K. & Sinha, A. D. Masked uncontrolled hypertension in CKD. J. Am. Soc. Nephrol. http://dx.doi.org/10.1681/ASN.2015030243 (2015).

  3. Sheikh, S., Sinha, A. D. & Agarwal, R. Home blood pressure monitoring: how good a predictor of long-term risk? Curr. Hypertens. Rep. 13, 192–199 (2011).

    Article  Google Scholar 

  4. McManus, R. J. et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial. Lancet 376, 163–172 (2010).

    Article  Google Scholar 

  5. Agarwal, R., Bills, J. E., Hecht, T. J. & Light, R. P. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 57, 29–38 (2011).

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Rajiv Agarwal.

Ethics declarations

Competing interests

R.A. has consulted for pharmaceutical companies that make antihypertensive drugs: Abbvie, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Johnson and Johnson, Merck, Novartis and Takeda. He serves on the steering committees of clinical trials funded by Bayer, Celgene, Johnson and Johnson, Opko and Relypsa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agarwal, R. Rest before blood pressure measurement: a lesson from SPRINT. Nat Rev Nephrol 12, 127–128 (2016). https://doi.org/10.1038/nrneph.2016.2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrneph.2016.2

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing